Market Newsdesk

DENVER, CO, May 04, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC” or “Company”) is pleased to announce that on April 30, 2021, Colorado’s Marijuana Enforcement Division (MED) and the City of Colorado Springs granted regulatory approvals for the Company’s acquisition and operation of Medihemp, LLC, and its wholly owned subsidiary SLAM Enterprises, LLC, and Medical Cannabis Caregivers, Inc., all doing business as Naturaleaf™, a long-standing vertically integrated cannabis business.

As a result of the regulatory approvals and the closing of the asset purchase, the Company acquired Naturaleaf’s three medically licensed retail stores, and a 10,000 square foot cultivation and extraction facility located in the metropolitan area of Colorado Springs. Naturaleaf™ has earned a strong reputation for its quality products and customer experience, having served its loyal and growing patient base since 2009.

“We are incredibly happy to have completed this acquisition, and this is only the beginning,” said Terry Buffalo, Chief Executive Officer of American Cannabis Company. Buffalo continued, “With the approval from the regulatory bodies now behind us, this is where the real work starts. Brand integration is key for success, and our team is working diligently to dial in processes and procedures, as well as implementing ACC’s company culture and core values, while also maintaining Naturaleaf™ brand integrity. We look to expand production capacities by revamping the cultivation operation, adding technology and equipment, including our proprietary cultivation methodologies and ‘just add water’ all-natural potting mix, SoHum Living Soils®, to effectively grow a consistent, high-value flower product. In addition to the modifications we plan to make in the back of the house, we also aim to elevate the retail experience by adding best-in-market products, new retail equipment and technologies to maximize customer/patient experience, as well as maintain consistent inventories. With this acquisition we anticipate over $2mm+ in gross revenue, and we look to increase upon that. For more details, please read the Company’s most recent 8-K filings.”

Scott Saunders, owner of Naturaleaf™, commented: “We are happy to have been acquired by American Cannabis Company. Since 2009 Naturaleaf has been pioneering the local medical market. The staff is excited to transition under the ownership of a public company, and I am excited for the people of Colorado Springs to see what American Cannabis Company is going to bring to the local community.”

Overall Transaction Background

On December 10, 2020, American Cannabis Company announced that it had executed a non-binding letter of intent to acquire all three (3) Naturaleaf™ medical marijuana centers along with its ten thousand (10,000) square foot commercial cultivation facility that also includes non-volatile extraction facilities.

On March 11, 2021, American Cannabis Company announced that it had executed the official Asset Purchase Agreement (APA) and on April 20, 2021 the Company received a contingent approval letter from Colorado’s Marijuana Enforcement Division (MED), outlining the change of ownership.

After now having obtained final regulatory approval transferring the Naturaleaf™ licenses to the Company, and finalizing the closing of the asset purchase transaction as of April 30, 2021, the Company plans to acquire additional local and national cannabis assets and brands, with the goal of creating a portfolio of cannabis assets elevating the consumer experience through a commitment to wellness, quality products, and cleaner green practices.

For a complete disclosure of the asset purchase agreement, see the Company’s Form 8-K filed with the Securities and Exchange Commission:

https://www.sec.gov/Archives/edgar/data/945617/000172186821000142/f2sammj8k031121.htm

For a complete disclosure of the acquisition for Naturaleaf™ and the received regulatory approval, see the Company’s Form 8-K filed with the Securities and Exchange Commission:

https://www.sec.gov/Archives/edgar/data/945617/000172186821000254/f2sammj8k043021.htm

About American Cannabis Company, Inc.

American Cannabis Company, Inc. offers end-to-end solutions to existing and aspiring participants in the cannabis and hemp industries. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. We are continuing to grow the company by promoting our operational management services and license the American Cannabis Company brand as well as continuing to analyze acquisition opportunities worldwide. American Cannabis Company also developed and owns a portfolio of branded products including: SoHum Living Soils® – Winner of the High Times S.T.A.S.H. Award for “Best Potting Mix,” The Cultivation Cube™ and the High-Density Cultivation System™. American Cannabis Company also designs and provides other industry-specific custom product solutions.

For more information about American Cannabis Company, please visit:

www.theacclife.com

www.americancannabisconsulting.com

www.americancannabiscompanyinc.com

www.sohumsoils.com

www.americanhempservices.com

Video Links:

https://americancannabisconsulting.com/resources/video/ (ACC Site)

https://www.youtube.com/watch?v=aENC4aeNZis (High Density Cultivation System)

https://www.youtube.com/watch?v=e9rNxFph_tQ&t (Cultivation Cube)

https://www.youtube.com/watch?v=XoIcopO2yE8&t (SoHum Living Soils®)

About Naturaleaf™

Naturaleaf™, a well-known brand frequently sought out by locals in the Colorado Springs area, has been providing medical patients with cannabis and cannabis-derived products for over ten (10) years. Its staff and patient specialists maintain a very active presence in the local community, strive to find patients the right medicine for present or given conditions, and promote cannabis education to its patrons in a one-on-one retail concierge experience.

For more information on Naturaleaf™, please visit:

www.thenaturaleaf.com

Contact:

[email protected]

303-974-4770

Forward-Looking Statements

This news release contains “forward-looking statements,” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”. These or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time to time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

Cannabis Remains an Illegal Schedule 1 Drug Under Federal Law

Thirty-five states, including Colorado, the District of Columbia and four U.S. Territories currently have laws broadly legalizing cannabis in some form for either medicinal and/or recreational use governed by state specific laws and regulations. Although legalized in some states, cannabis is a “Schedule 1” drug under the Controlled Substances Act (21 U.S.C. § 811) (“CSA”) and is illegal under federal law. Cannabis and its derivatives are viewed as being highly addictive and having no medical value. The United States Drug Enforcement Agency enforces the Controlled Substances Act, and persons violating it are subject to federal criminal prosecution.

As a result of the November, 2020 federal elections, and the election of Joseph R. Biden as president, it is expected that the federal government will move to amend parts of the CSA and de-schedule cannabis as a Schedule 1 drug.

In late January, 2021, Senate Majority Leader Chuck Schumer said lawmakers are in the process of merging various cannabis bills, including his own legalization legislation. He is working to enact reform in this Congressional session. This would include the Marijuana Freedom and Opportunity Act, that would federally de-schedule cannabis, reinvest tax revenue into communities most affected by the drug war, and fund efforts to expunge prior cannabis records. It is likely that the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act would be incorporated.

Other federal legislation under review for possible submission includes the SAFE Banking Act (or Secure and Fair Enforcement Act), a bill that would allow cannabis companies to access the federally-insured banking system and capital markets without the risk of federal enforcement action, and the Strengthening the Tenth Amendment Through Entrusting States Act (or STATES Act), a bill that seeks protections for businesses and individuals in states that have legalized and comply with state laws.

Notably with respect to our business, on November 1, 2019, Colorado Bill HB-19-1090, was passed and made effective. This law allows publicly traded corporations to apply for and qualify for the ownership of Colorado cannabis licenses. Other states that have legalized cannabis for recreational and/or medicinal use restrict public companies from owning interests in state cannabis licenses altogether, or have enacted regulations which make it difficult for corporations to comply with application requirements, including all shareholders submitting to and passing background checks.

On September 18, 2020, Colorado’s Marijuana Enforcement Division (MED), approved the Company’s application for suitability, establishing the Company as one of the few publicly traded companies authorized to acquire and operate various cannabis licenses throughout Colorado, in both the recreational and medical markets.

LAKE OSWEGO,OR, May 04, 2021 (GLOBE NEWSWIRE) — Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global Trac” “PSYC” or the “Company”) the first publicly traded digital media company within the emerging sector of medicinal psychedelics, is pleased to provide its shareholders with an update on the Company’s investment in The Conscious Fund (the “Fund”), an early-stage venture capital fund focused on the emerging sector of medicinal psychedelics.

This January, the Company completed its initial investment into the Fund via their private placement memorandum made available to qualified investors. And, in the few short months since completing their initial investment, the Company contends that the Fund has added significant value to its impressive portfolio of early-stage companies involved within the medicinal psychedelics industry.

A few highlights of note are the addition of Wesana Health Inc. to the Fund’s portfolio, a life sciences company focused on developing solutions for traumatic brain injury and led by ex-NHL enforcer and 2x Stanley Cup winner, Daniel Carcillo. Last month, Wesana Health announced the closing of their oversubscribed private placement in the amount of CAD $16.1 million which, in addition to the Fund, included investments from Ambria Capital, LLC and George Steinbrenner IV.

Additionally, the Fund has also added April 19 Discovery, Inc., a psychedelic AI-focused company into its portfolio and which the Fund contends is already demonstrating profitability.

And furthermore, ATAI Life Sciences, Albert Labs, and MagicMed Industries, each continue to make significant progress with their respective go-public strategies and appear to be on track to potentially enter the public markets in the very near future.

When asked about the significance of the Fund’s progress from a value perspective for PSYC, Global Trac Solutions, Inc. CEO, David Flores, said the following:

“Our decision to position PSYC as early investors in the Fund was positively strategic. Fueled by the sound business acumen and dedication of its Co-Founding Partners, we recognized the value of the portfolio they were assembling and the potential many of these companies have in terms of becoming leaders in an industry which, according to Data Bridge Market Research, is expected to grow to $6.85 billion-dollars by 2027. The growing amount of interest and excitement many of these companies are seeing from the public market and investment communities, in my opinion, lends to the long-term value potential I see in this investment and what it can hopefully deliver to PSYC and our shareholders in the years to come.”

“We are very grateful to count on the continued support of David and rest of the Global Trac team,” said Michael Hoyos, The Conscious Fund Co-Founding Partner – Americas. “As we continue building out the Fund’s media strategy, we feel lucky to have Global Trac’s world-class expertise behind us; the Psychedelic Spotlight platform in particular has been a fantastic resource to leverage. Jill Ettinger and her team have been a dream to work with and we look forward to more collaboration in the future!”

About Global Trac Solutions, Inc. (OTCPink: PSYC)

At Global Trac Solutions we are integrating media, creativity, and technology to develop and deploy thought-provoking ideas and solutions that are fostering and transforming the approach to some of society’s most pressing matters.

PSYC has expressed its intent and commitment to positioning itself at the forefront of the psychedelic revolution and as a resource center for discovering and understanding the latest research and business opportunities surrounding psychedelic inspired medicines. In conjunction with the FDA’s more open-minded approach to psychedelic medicines, and as several major U.S. cities continue to approve the decriminalization of psilocybin, investors are speculating that the psychedelic boom could be bigger than that of cannabis. PSYC is your source for current investment related news specific to psychedelic medicines and cutting-edge research improving overall health, moving this sector into the mainstream.

We believe in a forward-thinking approach that embraces groundbreaking new technology and innovations and through the vision of business development we intend to continue to evolve into these unchartered territories as the industry leaders of the future. We truly are the right TRAC to follow.

Forward-Looking Statements Disclaimer:

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “ongoing,” “plan,” “potential,” “predict,” “project,” “should,” “will,” “would,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors, including the effect of COVID-19, that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are disclosed on the OTC Markets.com website.

Disclaimer: Global
Trac
Solutions, Inc. does not in any way encourage or condone the use, purchase, sale or transfer of any illegal substances, nor do we encourage or condone partaking in any unlawful activities. We support a harm reduction approach for the purpose of education and promoting individual and public safety. If you are choosing to use psychedelic subs
tances, please do so responsibly.

Corporate Contact:

Global Trac Solutions, Inc. (PSYC)
www.globaltracsolutions.com
(702) 239-1919
[email protected]
OTCPINK: PSYC

VANCOUVER, British Columbia and MOORSETOWN, N.J., May 04, 2021 (GLOBE NEWSWIRE) — IT Glue™, a Kaseya company and the industry standard for automated IT documentation, today announced the acquisition of TruMethods, the MSP industry’s leading business transformation organization. The acquisition is the culmination of work between the companies to integrate myITprocess™ with IT Glue, and deliver the most powerful, high-value virtual CIO (vCIO) software platform to allow MSPs to build more strategic relationships with their customers.

“As MSPs mature, a vCIO offering will become a must-have capability in their arsenal,” said Nadir Merchant, CTO and general manager, IT Glue. “Ninety-five percent of myITprocess users use IT Glue, which demonstrates just how well our products go hand-in-hand. As we worked on this integration, it became clear that we could do so much more for the MSP community by going beyond just the technology. This acquisition is a milestone for our industry as Gary Pica – a legend in the MSP space – and his team join forces with IT Glue to take MSPs to even greater heights.”

myITprocess is the industry’s leading vCIO solution that enables MSPs to deliver world-class technical services through a proactive, repeatable process. MSPs use myITprocess to quickly analyze clients’ technical environments, establish their IT standards, make business recommendations, track client feedback, and develop custom, strategic roadmaps specific to each client. Together with IT Glue, MSPs have a one-two punch that synchronizes all their IT Glue configurations and assets within myITprocess. In doing so, documentation details are seamlessly updated within myITprocess to accurately guide client quarterly business reviews that open the doors to new projects, new sources of revenue and stronger client relationships.

“Bringing myITprocess and IT Glue together was a natural fit,” said Gary Pica, founder and president, TruMethods. “When I founded TruMethods over a decade ago, my goal was to make life easier for MSP owners and that is what we’ve done here by combining our technologies. The inherent synergies between our two industry leading products deliver unparalleled knowledge sharing, efficiency and profitability that MSPs cannot ignore. My mission has always been to help MSPs succeed by delighting their customers and that is what this integration delivers. This new era for TruMethods as part of the IT Glue family puts us in an even better position to help more MSPs reach their full potential.”

“The MSP community is indebted to Gary for the incredible work he’s done throughout his career,” said Fred Voccola, CEO, Kaseya. “The training, peer group and software he and his team have built have completely changed the way MSPs transform their business. Kaseya and IT Glue are committed to doing what’s right for the MSP industry. I can’t think of a better way to do that than by enabling TruMethods and Gary to reach even more MSPs around the world with their unmatched knowledge, independence, expertise and services.”

TruMethods and its peer groups will continue to be led by Gary Pica and his team from the company’s offices in New Jersey.

For more information on the myITprocess and IT Glue integration visit: www.itglue.com/myitprocess.

About TruMethods

TruMethods is a business transformation organization launched in 2009 by industry leader Gary Pica. Gary started TruMethods with the purpose of sharing a proven framework to help MSPs achieve more recurring revenue sales and industry leading profitability. TruMethods combines training, community, software, and peer to help MSPs reach world-class results. The FormulaWon coaching program, vCIO software – myITprocess, and world-class peer group TruPeer are changing the way MSPs operate. Nearly 20% of the Channel Futures 501 are powered by the TruMethods Framework. For more information, visit www.trumethods.com and connect on Twitter, LinkedIn and Facebook.

About IT Glue 

IT Glue, a Kaseya company, is the leading provider of simple and secure IT documentation for IT professionals around the globe. Our solution empowers IT professionals to document applications, devices, passwords and other IT assets centrally and in a standardized manner. Critical information is stored securely and easily accessed by those who need it, whenever they need it. Based in Vancouver, Canada, IT Glue currently has over 8,500 partners in 50+ countries, serving over 150,000 users and 500,000 businesses globally. For more information, visit: https://itglue.com and connect on LinkedIn and Twitter. 

About Kaseya

Kaseya® is the leading provider of IT and security management solutions for managed service providers (MSPs) and small to medium sized businesses (SMBs). Through its open platform and customer-centric approach, Kaseya delivers best in breed technologies that allow organizations to efficiently manage, secure, and backup IT. Kaseya IT Complete is the most comprehensive, integrated IT management platform comprised of industry-leading solutions from Kaseya, Unitrends, Rapidfire Tools, Spanning Cloud Apps, IT Glue, ID Agent, Graphus and RocketCyber. The platform empowers businesses to: command all of IT centrally; easily manage remote and distributed environments; simplify backup and disaster recovery; safeguard against cybersecurity attacks; effectively manage compliance and network assets; streamline IT documentation, and automate across IT management functions. Headquartered in Dublin, Ireland, Kaseya is privately held with a presence in over 20 countries. To learn more, visit www.kaseya.com.

Media Contacts
Katy Hoeper, PR Manager
Walker Sands
[email protected]

Kylie Banks, Corporate Communications Manager
Kaseya
[email protected]

LAS VEGAS, May 04, 2021 (GLOBE NEWSWIRE) — Live Ventures Incorporated (Nasdaq: LIVE), a diversified holding company, today announced preliminary record quarterly revenue for the second fiscal quarter ended March 31, 2021.

The company expects revenues for the quarterly period ended March 31, 2021 to be in the range of $68 million to $72 million, representing an increase of 46-55% compared to the same period last year.

“We experienced strong performance across our platform,” Live Ventures’ President and Chief Executive Officer Jon Isaac said, “and we are excited to share our potential record performance in full on May 17th.”

Live Ventures intends to file its Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2021 on May 17, 2021.

Forward-Looking and Cautionary Statements

The company has not yet closed and not yet finalized its financial statement review process for the second fiscal quarter ended March 31, 2021. As a result, the information in this release is preliminary and based upon information available to the company as of the date of this release, and therefore remains subject to the completion of the normal quarter-end accounting procedures and adjustments. During the course of the company’s review, items may be identified that would require the company to make adjustments, which could result in changes to its preliminary selected financial information above. As a result, the preliminary selected financial information above is forward-looking information and subject to risks and uncertainties, including possible adjustments to such information.   

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. In accordance with the safe harbor provisions of this Act, statements contained herein that look forward in time that include everything other than historical information, involve risks and uncertainties that may affect the company’s actual results, including but not limited to when the company expects to file its Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2021 and whether the company achieves record financial performance for such fiscal quarter. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” and similar statements. Live Ventures may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission on Forms 10-K and 10-Q, Current Reports on Form 8-K, in its annual report to stockholders, in press releases and other written materials and in oral statements made by its officers, directors, or employees to third parties. There can be no assurance that such statements will prove to be accurate and there are a number of important factors that could cause actual results to differ materially from those expressed in any forward-looking statements made by the company, including, but not limited to, plans and objectives of management for future operations or products, the market acceptance or future success of our products, and our future financial performance. The company cautions that these forward-looking statements are further qualified by other factors including, but not limited to, those set forth in the company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2020 (available at http://www.sec.gov). Live Ventures undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events, or otherwise.

About Live Ventures

Originally incorporated in 1968, Live Ventures Incorporated is a diversified holding company with several wholly owned subsidiaries and a strategic focus on acquiring profitable companies that have demonstrated a strong history of earnings power. Through its subsidiary Marquis Industries, the company manufactures and sells residential and commercial carpets primarily in North America. Marquis Industries also designs, sources and sells hard-surface flooring. Through its subsidiary Precision Marshall, the company manufactures and sells steel in four product categories: deluxe alloy plate, deluxe tool steel plate, precision ground flat stock, and drill rod. Through its subsidiary Vintage Stock, an award-winning entertainment retailer, the company sells new and pre-owned movies, classic and current generation video games and systems, music on CD & LP, collectible comics, books, toys, and more. Vintage Stock, through its stores and website, ships product worldwide directly to the customer’s doorstep. Through its subsidiary Precision Industries, the company sells premium tool steels and specialty alloys. Through its subsidiary ApplianceSmart, the company sells new major household appliances in the United States through a company-owned retail store in Columbus, Ohio operating under the name ApplianceSmart®. All Live Ventures companies are rooted in their local communities where they contribute to the local economy and serve as responsible corporate neighbors.

Contact:

Live Ventures Incorporated
Tim Matula, Investor Relations
(425) 836-9035
[email protected]
http://liveventures.com
Source: Live Ventures Incorporated

BOSTON, May 04, 2021 (GLOBE NEWSWIRE) — Charlesbank Capital Partners, LLC (“Charlesbank” or the “Firm”) is pleased to announce the election of John Flannery as Managing Director. As part of his expanded role, he will also co-lead the Firm’s Portfolio Resources Group (“PRG”). Before joining Charlesbank in 2019 in an advisory role, Mr. Flannery spent his career in various leadership roles at GE, most recently as Chairman and Chief Executive Officer.     

Over his 30-plus years at GE, Mr. Flannery held various leadership roles in the financial services and industrial arms, including CEO of: GE Equity, GE Capital Asia, GE India and GE Healthcare. Under his leadership, GE’s healthcare business established global technology leadership in core imaging, creating digital platforms and solutions, and expanded its Life Sciences and cell therapy systems businesses. He also launched Sustainable Healthcare Solutions, bringing disruptive technologies to healthcare providers across emerging markets.

Mr. Flannery has already been creating value in Charlesbank’s portfolio companies by working with CEOs and their teams to improve operating performance, strategy and governance. He has also helped to radically advance the effectiveness of the PRG team in driving consistent equity value in the portfolio overall. Mr. Flannery will continue to serve as a Director at portfolio companies Sound United, Hearthside Foods and Tecomet, in addition to working with Charlesbank’s investment team generally on new transactions.

“With his deep experience, pattern recognition and relationships, John has been a truly special addition to the Charlesbank team,” said Michael Choe, Managing Director and CEO at Charlesbank. “A natural and inclusive team-builder, he brings extraordinary leadership and deep commitment to our work, and we are privileged to have him join the partnership.”

“I am delighted to be spending the next chapter of my career at Charlesbank,” said Mr. Flannery. “I look forward to my continued work alongside the talented leaders of our portfolio companies and with the continued expansion of the Portfolio Resources Group, which will enable us to accelerate equity value growth across the portfolio.”

Mr. Flannery will co-lead Charlesbank’s growing Portfolio Resources Group along with fellow Managing Director Sam Bartlett. PRG augments the investment team during due diligence and supports portfolio companies through all phases of ownership to successful exit.

About Charlesbank Capital Partners

Based in Boston and New York, Charlesbank Capital Partners is a middle-market private investment firm with more than $15 billion of capital raised since inception. Charlesbank focuses on management-led buyouts and growth capital financings, as well as opportunistic credit and technology investments. The firm seeks to build companies with sustainable competitive advantage and excellent prospects for growth. For more information, please visit www.charlesbank.com.

Media Contact:

Charlesbank Capital Partners
Maura Turner, VP, Marketing & Communications
[email protected]
617-619-5457

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/74645efd-cf60-4fc7-9859-5de633c52457